Jones Day has advised BioMarin Pharmaceutical Inc. in the acquisition of Amicus Therapeutics. Kirkland & Ellis has advised Amicus Therapeutics. BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) has...
BioMarin to Acquire Amicus Therapeutics for $4.8 Billion
Sanofi’s $17 Billion Acquisition of Opella
Freshfields Bruckhaus Deringer is advising Sanofi, while Kirkland & Ellis and Debevoise & Plimpton are advising CD&R on the transaction. French drugmaker Sanofi and Clayton Dubilier...


























